Welcome to This is MS' information resources on Tysabri. Tysabri was formerly known as "Antegren," and in the medical literature, it is known as Natalizumab. Tysabri has received approval for the treatment of Relapsing-Remitting Multiple Sclerosis in November of 2004.
As the approval is so recent, this page is under ACTIVE construction-- so please check back often for our latest updates.
Tysabri Two-Year Monotherapy Trial Results Press ReleaseHere
Tysabri United States Food and Drug Administration (FDA) approval letter:
Here
Tysabri Product Information Label:
Here
Tysabri FDA Q&A:
Here
Tysabri Home Page by Elan/Biogen:
Here
Tysabri Online Education
Copyright © by This Is MS All Right Reserved.